RLMD Buy Disclosure
Shenouda Maged · SEC Form 4 · Filed Sep 11, 2026
Buy
Calculated transaction value
$504.84K
Shenouda Maged Chief Financial Officer
RLMD
Relmada Therapeutics
RLMD
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
RLMD daily price context
Close on/before transaction
$4.09
Sep 9, 2026
Close before public filing
$4.07
Sep 10, 2026
Return since public filing
+12.28%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 120,200 shares @ $4.2
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001213900-26-098970
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$843.99K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relmada Therapeutics, Inc. RLMD | Buy | Sep 10, 2026 | $339.15K |
| Relmada Therapeutics, Inc. RLMD Current | Buy | Sep 9, 2026 | $504.84K |